In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Anish Mehta, Chief Executive Officer (CEO) of Synthon.
Anish Mehta is a global pharmaceutical CEO whose career spans engineering, strategy consulting, commercial leadership, mergers and acquisitions (M&A), and private equity-backed transformation. From biomedical and chemical engineering to McKinsey, Baxter and Hospira, he has spent more than 25 years building businesses and creating value across innovative pharma and generics.
In this conversation, he shares how he built leadership from the shop floor up, what it takes to lead globally, and how he creates value through win-win deals. He also explains the discipline of a private equity-backed business, and why patient impact remains his North Star.
Click or tap the play button to watch the video or tune in on Spotify, Apple Podcast or Amazon Music.
Key Takeaways
- Learn why Anish Mehta names strategic conviction, growth mindset, authenticity and stamina as the ingredients that carry senior leaders through a demanding life sciences career.
- Discover how growth creates value only when it serves a purpose, with a North Star anchored to something bigger than the profit and loss account.
- Understand why the best leaders stay unapologetically human, taking the work seriously without taking themselves too seriously.
- Explore how a summer milling antibiotic ingredients on Abbott’s shop floor made Mehta a more relatable and empathetic executive decades later.
- Gain a practical dealmaking principle: grow the size of the pie for both sides rather than fight over how a fixed pie is split.
- Identify what separates a great dealmaker from a good one, namely the discipline to walk away when deal fever takes hold.
- Apply lessons on leading a private equity-backed company, where accountability is absolute, and alignment on a credible plan comes first.
- Take away why a better company means more than earnings, including a stronger pipeline, wider geographical footprint and greater patient impact.
- Uncover Mehta’s advice for the next generation: align work with your values, ignore the risk-averse voice, and become as AI literate as possible.
Snippets
- “When I win, and they lose, that is not success… I focus on how we increase the size of the pie, not how we split the pie.”
- “The simplest one is knowing when to walk away. Too many people get deal fever… deal fever is a real thing. I’ve been in the room, I’ve seen it.”
- “Take the roles that the little voice inside you says, are you sure, should you do it, is it risky. Don’t listen to that voice. Take the roles that give you a chance to shine.”
Timestamps & Topics
The following timestamps are approximations:
- [00:00] – Intro: Anish Mehta’s journey from Chicago to global pharma CEO
- [02:58] – Key Ingredients: Strategic conviction, growth mindset, authenticity, stamina
- [13:23] – Shop Floor: What milling APIs at Abbott taught him about leadership
- [28:39] – Stepping Up: The 2007 challenge that made him a business leader
- [42:50] – Dealmaker Mindset: Building win-win partnerships in generics
- [48:56] – Private Equity: Leading with full accountability as a PE-backed CEO
- [1:06:17] – Advice: What he tells the next generation of life science leaders
Resources
Follow Anish Mehta on LinkedIn: https://www.linkedin.com/in/anish-mehta-66615a/
Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/
Don’t Miss an Episode. Join the Community
Sign up to the Active Ingredients podcast at www.activeingredients.fraserdove.com.
Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Amazon, Spotify, YouTube and other leading podcast platforms.
Feedback?
Have questions or feedback about the podcast or want to feature as a guest? Email us at hello@activeingredients.fraserdove.com
Loved this episode?
Share it with your friends, family or your peers!
RELATED
Building Win-Win Deals in Generics With Anish Mehta
Read post
Courage, Reinvention & Talent Development in Life Sciences with Michaela Griggs
Read post
Bridging commercial and operations in CDMO with Michael Stanek
Read post
Situational Leadership and Team DNA in Life Sciences Operations with Tom Hochuli
Read post
Why diversity of thinking builds better oncology teams with Yariv Hefez
Read post